Search Results Search Sort by RelevanceMost Recent Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701. Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701. Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.
Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701.
Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701.
Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.